Comparison

Thalidomide-O-amido-PEG2-C2-NH2 TFA European Partner

Manufacturer TargetMol
Category
Type Inhibitors
Specific against other
Amount 5 mg
Item no. TMO-T17918-5mg
Targets TF
CASRN 1957235-75-4
eClass 6.1 30220300
eClass 9.0 32160605
Available
Alias E3 Ligase Ligand-Linker Conjugates 24 TFA , Cereblon Ligand-Linker Conjugates 10 TFA
Short Description
Thalidomide-O-amido-PEG2-C2-NH2 TFA is a synthesized E3 ligase ligand-linker conjugate. Thalidomide-O-amido-PEG2-C2-NH2 TFA incorporates the Thalidomide based cereblon ligand and 2-unit PEG linker used in PROTAC technology.
Shipping
cool pack
Storage
-20°
Target names or alias
E3 Ligase Ligand-Linker Conjugates 24 TFA , Cereblon Ligand-Linker Conjugates 10 TFA
Molecular Weight
576, 48
Pathway
PROTAC|||Others
Target
Others|||E3 Ligase Ligand-Linker Conjugate

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 5 mg
Available: In stock
available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close